Key regions: United Kingdom, Canada, Japan, Europe, China
The demand for dermatological drugs in Mozambique has been on the rise in recent years, driven by various factors such as increasing awareness of skin diseases and growing disposable income.
Customer preferences: Mozambique's population has been experiencing a shift towards urbanization and westernization, which has influenced their preferences for skincare products. Customers are increasingly seeking out dermatological drugs that are effective in treating skin diseases such as acne, eczema, and psoriasis. Additionally, customers are also looking for products that are affordable and easily accessible.
Trends in the market: The dermatological drugs market in Mozambique is expected to grow in the coming years, driven by factors such as increasing demand for skincare products, rising disposable income, and growing awareness of skin diseases. The market is also expected to benefit from the entry of new players who are bringing in innovative products to the market. However, the market is also facing challenges such as the lack of adequate healthcare infrastructure and the high cost of some dermatological drugs.
Local special circumstances: Mozambique is a developing country with a relatively low GDP per capita, which means that affordability is a key consideration for customers when choosing dermatological drugs. Additionally, the country has a high prevalence of skin diseases due to factors such as poor hygiene, inadequate sanitation, and exposure to the sun. This has led to an increased demand for dermatological drugs that can effectively treat these diseases.
Underlying macroeconomic factors: Mozambique's economy is heavily reliant on agriculture, which accounts for over a quarter of the country's GDP. The country has also been experiencing a period of political stability, which has led to increased foreign investment and economic growth. Additionally, the country's population is young and growing, which means that there is a large potential market for skincare products. However, the country also faces challenges such as high levels of poverty, inadequate healthcare infrastructure, and a high burden of disease.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
